NCT00634387

Brief Summary

Anthocyans modify cardiovascular and sympathetic function

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Mar 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2008

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 13, 2008

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

July 6, 2011

Status Verified

February 1, 2010

Enrollment Period

1.3 years

First QC Date

March 5, 2008

Last Update Submit

July 3, 2011

Conditions

Hypertension

Outcome Measures

Primary Outcomes (1)

  • Systolic bloodpressure and heartrate

Study Arms (2)

A

ACTIVE COMPARATOR

Anthocyans

Dietary Supplement: Anthocyans

B

PLACEBO COMPARATOR

no effective agent

Dietary Supplement: AnthocyansOther: placebo

Interventions

AnthocyansDIETARY_SUPPLEMENT

Anthocyans

AB
placeboOTHER
B

Eligibility Criteria

Age35 Years - 50 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 35 to 50 years old
  • Males
  • Hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiovascular and Renal Research Center, Ulleval University Hospital

Oslo, 0407, Norway

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 5, 2008

First Posted

March 13, 2008

Study Start

March 1, 2008

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

July 6, 2011

Record last verified: 2010-02

Locations

NO(1)